News

Sun Pharmaceutical Industries Ltd reported robust financial growth for the second quarter of fiscal year 2025, posting a 28% year-over-year (YoY) increase in net profit,… Read More »Sun Pharma Achieves 28% YoY Profit Growth in Q2 FY25 to ₹3,040.16 Crore

Sanofi has shown confidence in the growing success of its RSV antibody, Beyfortus, despite potential competition from Merck’s upcoming RSV treatment, clesrovimab. Beyfortus, developed in… Read More »Sanofi Shrugs Off RSV Competition as Beyfortus Sales Skyrocket